Vaginal trichomoniasis poses a difficult therapeutic challenge when metronidazole is ineffective or contraindicated. We conducted a retrospective study of 6.25% paromomycin cream in the treatment of nine women referred with cases of vaginal trichomoniasis where metronidazole resistance or allergy was present. Results obtained immediately and 1 month after treatment were reviewed. The median age of the patients was 46 years; four women were nulliparous. The median symptom duration was 1 year. Five women were allergic to metronidazole. In four cases, resistance to high doses of metronidazole was demonstrated. Smears or cultures were positive immediately after treatment for three patients; a fourth relapsed 2 weeks later. Of these patients for whom treatment failed, one was cured with a 3-week course of paromomycin cream, and another was successfully treated with paromomycin cream and oral tinidazole. Three patients developed vaginal ulcerations that resolved spontaneously. Adverse effects may be a result of local formulation. Paromomycin cream was useful for treatment of cases of trichomonas infection where metronidazole resistance or allergy was encountered.
Vaginal infections caused by Trichomonas vaginalis are among
Methods the most common sexually transmitted diseases in the United States; it is estimated that 3 million infections occur annually [1] .
The Vaginitis Centers at Temple University (Philadelphia) Metronidazole, given as either a single dose or a 7-day regimen, and Wayne State University (Detroit) were established to evaluis the only approved treatment in the United States. Cure rates of ate and treat women referred because of chronic vaginal symp-Ç95% can be expected [2] . For patients who do not respond to toms; in the aggregate, the centers evaluate Ç700 new patients treatment and in whom reinfection has been excluded, increasing per year. A retrospective chart review of patients receiving doses of metronidazole are recommended. For patients who are paromomycin cream from August 1995 to November 1997 was allergic to metronidazole, the guidelines of the Centers for Disease performed. Patients with trichomonas infections proven at our Control and Prevention do not offer any alternative therapy, alcenters by either a saline preparation positive for motile trichothough desensitization to metronidazole has been used successmonads or a culture positive for Trichomonas were offered fully for two patients [3] . paromomycin cream if there was documented clinical resisParomomycin, an aminocyclitol antibiotic derived from tance to metronidazole or a history of serious manifestations Streptomyces fradiae, has a spectrum of activity that includes allergy to metronidazole. Demographic data were obtained. many protozoa. In 1995, we reported the case of a woman with Patients had been followed up with visits immediately and 4 -6 infection due to metronidazole-resistant Trichomonas who was weeks after the 2-week course of paromomycin cream. Patients cured with a 2-week course of 6.25% paromomycin cream [4] . either avoided sexual intercourse or used latex condoms during We describe herein our experience with paromomycin cream sexual intercourse during the follow-up period to exclude the in a larger series of patients referred with cases of trichomonas possibility of reinfection. Cultures for T. vaginalis were perinfections where metronidazole was either ineffective or conformed if clinically indicated (i.e., persistent symptoms or findtraindicated.
ings of saline microscopy such as increased polymorphonuclear leukocytes suggestive of infection but where the organism could not be visualized).
Paromomycin is an amorphous, white to light yellow powder [5] . Trichomoniasis in the presence of a metronidazole allergy 2-week course of paromomycin cream. The median age of the also seems to be rare, with no cases described in a series patients was 46 years (range, 29 -50 years); four women (44%) of 45 patients seen at a chronic vaginitis center [5] . Clinical were nulliparous. The median duration of symptoms was 1 experience with desensitization to metronidazole in the setting year (range, 0.3 -14 years), and all the patients noted that they of trichomoniasis is limited to two patients [3] . Our experience had been given a diagnosis of vaginal trichomoniasis at the with one patient suggests that certain allergic reactions to metonset of their symptoms. Five women received paromomycin ronidazole are not amenable to desensitization. because of a history of allergic reactions to metronidazole, Although true cases of trichomoniasis where there is metroconsisting of urticarial skin reactions in 3, generalized edema nidazole resistance or a metronidazole allergy are rare, the in 1, and anaphylactic shock in 1. In the other four cases, options for their treatment are very limited, and these patients resistance to high doses of metronidazole had been demonpose a difficult challenge. In vitro studies have shown that strated. The highest doses of metronidazole that were used mebendazole, furazolidone, and rifabutin are the drugs most were a 2-week course of 1 g of oral metronidazole given twice active against metronidazole-resistant trichomonads [6] . Clinidaily in two cases and a 2-week course of 1 g of oral metronidacal experience with these medications is either lacking or, in zole together with 500 mg of intravaginal metronidazole given the case of mebendazole, disappointing [7] . Alternative treatthree times daily in two cases.
ments that have been used with variable success include sysImmediately after completion of paromomycin treatment, temic tinidazole [8] , povidone-iodine douches [9] , and nonoxysaline smears from all patients except for one were negative nol 9 [10]. For women for whom these treatments fail, including for Trichomonas. However, cultures for two patients were posiprolonged courses of high doses of metronidazole, their chronic tive and a fourth patient's infection relapsed 2 weeks after infections can cause profound morbidity, ranging from local treatment. Of these four patients for whom treatment failed, symptoms and discomfort to extensive psychosocial ramificatwo were retreated with a 3-week course of paromomycin tions of having a chronic incurable sexually transmitted disease. cream; one of these patients was cured. Overall, six of nine Paromomycin was studied in the early 1960s as a possible women were cured with paromomycin cream alone; all of the treatment for trichomoniasis. Because it is not absorbed from cured patients had complete resolution of their vaginal sympthe gastrointestinal tract, it has been studied only in topical toms.
formulations. An initial study by Dumont and colleagues [11] One patient for whom treatment failed subsequently did not suggested that it might be effective. Subsequently, Spitzbart respond to a combination of 500 mg of oral tinidazole four [12] studied 57 women who received 30-mg vaginal suppositotimes daily and 500 mg of intravaginal tinidazole twice a day; ries three times a day and found a 63% failure rate; he recomshe was given a combination of paromomycin cream for 5 days mended abandoning this treatment in favor of metronidazole. and 500 mg of oral tinidazole four times daily for 14 days.
In our study, patients received 250 mg of paromomycin per Treatment failed for two other patients who were allergic to applicator; the higher dose may explain our efficacy rate. metronidazole. One of them was successfully desensitized to After our initial success with 6.25% paromomycin cream and treated with metronidazole. The second one had a fixed [4] , we decided to offer it as treatment to patients for whom drug reaction to metronidazole and could not be desensitized; metronidazole was not an acceptable therapy because of resisshe remained infected at the time of this writing. tance or allergy. In this report, the largest published series Three patients developed mild irritation following adminisof refractory trichomonal infections, our results indicate that tration of paromomycin cream. Three patients had vaginal ulparomomycin is an effective alternative treatment for vaginal cerations during the treatment that later resolved spontaneously. trichomoniasis in patients unresponsive or allergic to nitroimidAll three were treated at the same clinic, and we believe that azole agents. Our ninth patient, for whom treatment initially this adverse effect may have been a result of the formulation failed, serves to emphasize how difficult these cases with metat that site. However, there were no obvious differences in ronidazole resistance or allergy can be. After her initial treatformulation between the two pharmacies. ment with paromomycin, she received a high dose of another alternative agent, tinidazole, but she did not respond. With no other known treatments and somewhat out of desperation, she Discussion was given a combination of oral tinidazole and paromomycin cream, which resulted in a clinical and microbiological cure. Although trichomoniasis is a relatively common sexually transmitted infection, it is fortunate that T. vaginalis remains Of some concern, however, are local adverse events. Although these effects were self-limited and observed only at one for the most part highly susceptible to metronidazole; cure rates associated with standard oral regimens exceed 95% [2] . Even clinic, further experience with this medication is necessary to obtain more accurate information with regard to efficacy and in clinical settings that specialize in seeing women with chronic / 9c4a$$ap61 03-09-98 19:22:24 cidas UC: CID
